Barbara Rizzardi
Internal Medicine · Sandy, UTNPI 1245385319
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $24,182 of the $29,886 with a category attached, or 80.9%. 24 manufacturers reported payments, led by Hoffmann-la Roche Limited at 38.7% of the total. 2025 is the largest year on record at $15,359, 3.4 times the $4,481 reported in 2019. Among internal medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $174.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hoffmann-la Roche Limited$12K
- Merck$8K
- Boehringer Ingelheim$2K
- Radius Health, Inc.$2K
- Amgen$2K
- Modernatx, Inc.$2K
- plus $3K from 18 others
Across 4,900 payments — averaging $5722.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$8.8M
- Emergent Biosolutions Inc.$3.2M
- Pfizer$3M
- AstraZeneca$2.8M
- GSK$1.5M
- Seqirus USA Inc$991K
- plus $7.8M from 28 others
What the payments were for
- Travel & lodging$24,18281%
- Food & beverage$5,69219%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hoffmann-la Roche Limited | 4 | $11,580 |
| Merck | 62 | $8,085 |
| Boehringer Ingelheim | 12 | $2,194 |
| Radius Health, Inc. | 13 | $1,876 |
| Amgen | 9 | $1,857 |
| Modernatx, Inc. | 4 | $1,659 |
| Boehringer Ingelheim International GmbH | 11 | $1,337 |
| AstraZeneca | 13 | $502 |
| AbbVie(2 entities) | 7 | $151 |
| Idorsia Pharmaceuticals US Inc | 2 | $134 |
| Pfizer | 7 | $112 |
| Amarin Pharma, Inc. | 5 | $83 |
| Boston Scientific | 3 | $58 |
| Novo Nordisk | 4 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $37 |
| Shire North American Group Inc | 2 | $28 |
| Gilead | 2 | $26 |
| Lilly USA, LLC | 2 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| GSK | 1 | $13 |
| Nalpropion Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,886 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.
Other internal medicine in Sandy
- James StewartSandy$5K
- Willard DereSalt Lake City$4.7M
- Kenneth SchaecherWest Valley City$333K
- Steven CallSpringville$178K
- James ChamberlainSalt Lake City$106K
- Alexander PastuszakSalt Lake City$87K
- Zameer AbedinSalt Lake City$83K
- Kashif MemonVernal$73K
- Gerald GleichSalt Lake City$22K
- Brian HornerSalt Lake City$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.